208 related articles for article (PubMed ID: 3104069)
1. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
[TBL] [Abstract][Full Text] [Related]
2. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
3. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
5. The TSH secretion in the human pituitary adenomas.
Trouillas J; Girod C; Loras B; Claustrat B; Sassolas G; Perrin G; Buonaguidi R
Pathol Res Pract; 1988 Sep; 183(5):596-600. PubMed ID: 3237550
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-secreting pituitary adenomas: report of seven cases.
Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
[TBL] [Abstract][Full Text] [Related]
8. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
9. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
10. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
11. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A
J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
[TBL] [Abstract][Full Text] [Related]
15. Apparently silent somatotroph adenomas.
Pagesy P; Li JY; Kujas M; Peillon F; Delalande O; Visot A; Derome P
Pathol Res Pract; 1991 Dec; 187(8):950-6. PubMed ID: 1792191
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic hormone detection in hypophyseal adenomas: correlation of serum hormone findings with immunocytochemical hormone levels in tumor tissue].
Knosp E; Krisch K; Schmidbauer M; Budka H
Wien Klin Wochenschr; 1988 May; 100(10):322-5. PubMed ID: 2840774
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
[TBL] [Abstract][Full Text] [Related]
18. Human mixed somatotrophic and lactotrophic pituitary adenomas.
Corenblum B; Sirek AM; Horvath E; Kovacs K; Ezrin C
J Clin Endocrinol Metab; 1976 May; 42(5):857-63. PubMed ID: 773951
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
[TBL] [Abstract][Full Text] [Related]
20. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]